Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
Jae-Hyeon Kim, Jun-Ho Ahn, Michael Lee
Cancer Res Treat. 2017;49(4):947-959.   Published online 2017 Jan 3     DOI: https://doi.org/10.4143/crt.2016.280
Citations to this article as recorded by Crossref logo
Tumor microenvironment responded naturally extracted FOF1-ATPase loaded chromatophores for antitumor therapy
Weiyong Hong, Bang Lou, Ying Gao, Hui Zhao, Sanjun Ying, Saicheng Yang, Hanbing Li, Qingliang Yang, Gensheng Yang
International Journal of Biological Macromolecules.2023; 230: 123127.     CrossRef
MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation
Elizabeth Proaño-Pérez, Laia Ollé, Yanru Guo, Cristina Aparicio, Mario Guerrero, Rosa Muñoz-Cano, Margarita Martin
International Journal of Molecular Sciences.2023; 24(4): 3515.     CrossRef
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
Elisabetta Fratta, Giorgio Giurato, Roberto Guerrieri, Francesca Colizzi, Jessica Dal Col, Alessandro Weisz, Agostino Steffan, Barbara Montico
Cell Death Discovery.2023;[Epub]     CrossRef
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, Stefania Rossi, Maria Elena Pisanu, Maria Bellenghi, Carla Lintas, Claudio Tabolacci
Cancers.2023; 15(16): 4026.     CrossRef
METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation
Shuai Qian, Jun Liu, Wenliang Liao, Fengping Wang
Epigenomics.2023; 15(23): 1237.     CrossRef
A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri, Mohammad Samadian
Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
Lauretta Levati, Cristian Bassi, Simona Mastroeni, Laura Lupini, Gian Carlo Antonini Cappellini, Laura Bonmassar, Ester Alvino, Simona Caporali, Pedro Miguel Lacal, Maria Grazia Narducci, Ivan Molineris, Federica De Galitiis, Massimo Negrini, Giandomenico
Cancers.2022; 14(15): 3706.     CrossRef
Paradoxical downregulation of LPAR3 exerts tumor-promoting activity through autophagy induction in Ras-transformed cells
Sung-Hee Hwang, Hye-Gyo Kim, Michael Lee
BMC Cancer.2022;[Epub]     CrossRef
SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microphthalmia-Associated Transcription Factor, Decreasing the Proliferation of Gastrointestinal Stromal Tumors
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Cindy Mancia, Arnau Navinés-Ferrer, Mario Guerrero, Margarita Martin
Cancers.2022; 14(24): 6198.     CrossRef
Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells
Min Seung Lee, So Hyun Lim, Ah-Ran Yu, Chi Yeon Hwang, Insug Kang, Eui-Ju Yeo
Biology.2021; 10(2): 153.     CrossRef
Resistance to Molecularly Targeted Therapies in Melanoma
Meet Patel, Adam Eckburg, Shahina Gantiwala, Zachary Hart, Joshua Dein, Katie Lam, Neelu Puri
Cancers.2021; 13(5): 1115.     CrossRef
Learning from Embryogenesis—A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development
Lisa Linck-Paulus, Lisa Lämmerhirt, Daniel Völler, Katharina Meyer, Julia C. Engelmann, Rainer Spang, Norbert Eichner, Gunter Meister, Silke Kuphal, Anja Katrin Bosserhoff
Journal of Clinical Medicine.2021; 10(11): 2259.     CrossRef
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246
Xuehan Bi, Xiao Lv, Dajiang Liu, Hongtao Guo, Guang Yao, Lijuan Wang, Xiaolei Liang, Yongxiu Yang
Cell Death Discovery.2021;[Epub]     CrossRef
Choosing The Right Animal Model for Renal Cancer Research
Paweł Sobczuk, Anna Brodziak, Mohammed Imran Khan, Stuti Chhabra, Michał Fiedorowicz, Marlena Wełniak-Kamińska, Kamil Synoradzki, Ewa Bartnik, Agnieszka Cudnoch-Jędrzejewska, Anna M. Czarnecka
Translational Oncology.2020; 13(3): 100745.     CrossRef
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma
Sara Carpi, Beatrice Polini, Stefano Fogli, Adriano Podestà, Erkko Ylösmäki, Vincenzo Cerullo, Antonella Romanini, Paola Nieri
Expert Review of Molecular Diagnostics.2020; 20(1): 19.     CrossRef
Autophagy inhibition in 3T3-L1 adipocytes breaks the crosstalk with tumor cells by suppression of adipokine production
Sung-Hee Hwang, Michael Lee
Animal Cells and Systems.2020; 24(1): 17.     CrossRef
Roles of S100 family members in drug resistance in tumors: Status and prospects
Xin Hua, Hongming Zhang, Jinfang Jia, Shanshan Chen, Yue Sun, Xiaoli Zhu
Biomedicine & Pharmacotherapy.2020; 127: 110156.     CrossRef
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Paolo Antonio Ascierto, Maria Vincenza Carriero
International Journal of Molecular Sciences.2020; 21(12): 4544.     CrossRef
Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains
Loredana Guglielmi, Marta Nardella, Carla Musa, Ingrid Cifola, Manuela Porru, Beatrice Cardinali, Ilaria Iannetti, Chiara Di Pietro, Giulia Bolasco, Valentina Palmieri, Laura Vilardo, Nicolò Panini, Fabrizio Bonaventura, Massimiliano Papi, Ferdinando Scav
Cancers.2020; 12(6): 1635.     CrossRef
MiR‐1246 promotes anti‐apoptotic effect of mini‐αA in oxidative stress‐induced apoptosis in retinal pigment epithelial cells
Qianyin Chen, Huimin Lin, Xuan Deng, Shengnan Li, Jinglin Zhang
Clinical & Experimental Ophthalmology.2020; 48(5): 682.     CrossRef
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Ilaria Proietti, Nevena Skroza, Nicoletta Bernardini, Ersilia Tolino, Veronica Balduzzi, Anna Marchesiello, Simone Michelini, Salvatore Volpe, Alessandra Mambrin, Giorgio Mangino, Giovanna Romeo, Patrizia Maddalena, Catherine Rees, Concetta Potenza
Cancers.2020; 12(10): 2801.     CrossRef
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma
Luigi Fattore, Rita Mancini, Paolo Antonio Ascierto, Gennaro Ciliberto
Expert Opinion on Therapeutic Targets.2019; 23(1): 53.     CrossRef
A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response
Ryan K. van Laar, Mitchel T. Lincoln, Barton J. van Laar
Melanoma Research.2019; 29(1): 19.     CrossRef
A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients
Zhiyan Wang, Jinru Lv, Xuan Zou, Zebo Huang, Huo Zhang, Qingxie Liu, Lin Jiang, Xin Zhou, Wei Zhu
Gene.2019; 693: 37.     CrossRef
The origin of exosomal miR-1246 in human cancer cells
Yi-Fan Xu, Bethany N. Hannafon, Ujjwol Khatri, Amy Gin, Wei-Qun Ding
RNA Biology.2019; 16(6): 770.     CrossRef
Differential Gene Expression Common to Acquired and Intrinsic Resistance to BRAF Inhibitor Revealed by RNA-Seq Analysis
Jun-Ho Ahn, Sung-Hee Hwang, Hyun-Soo Cho, Michael Lee
Biomolecules & Therapeutics.2019; 27(3): 302.     CrossRef
MicroRNA heterogeneity in melanoma progression
Anita Thyagarajan, Kenneth Y. Tsai, Ravi P. Sahu
Seminars in Cancer Biology.2019; 59: 208.     CrossRef
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Simona Caporali, Adriana Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar, Gian Carlo Antonini Cappellini, Nadia Felli, Alessandra Carè, Ulrich Pfeffer, Stefania D’Atri
Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53
Ran Xu, Huabing Li, Shuiqing Wu, Jian Qu, Haiyan Yuan, Yangang Zhou, Qiong Lu
International Urology and Nephrology.2019; 51(10): 1771.     CrossRef
The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers
Douglas Donnelly, Phyu P. Aung, George Jour
Seminars in Cancer Biology.2019; 59: 165.     CrossRef
Upregulation of S100A9 contributes to the acquired resistance to BRAF inhibitors
Sung-Hee Hwang, Jun-Ho Ahn, Michael Lee
Genes & Genomics.2019; 41(11): 1273.     CrossRef
Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway
Shaimaa A. Gad, Hamdy E. A. Ali, Rofaida Gaballa, Rania M. Abdelsalam, Mourad Zerfaoui, Hamed I. Ali, Salwa H. Salama, Sanaa A. Kenawy, Emad Kandil, Zakaria Y. Abd Elmageed
Scientific Reports.2019;[Epub]     CrossRef
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
Xiao Liu, Jinfeng Wu, Haihong Qin, Jinhua Xu
Targeted Oncology.2018; 13(4): 437.     CrossRef
Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor
Xiaohui Wang, Huajun Qu, Yinghe Dong, Guozhi Wang, Yuchen Zhen, Linxia Zhang
Cancer Biomarkers.2018; 23(1): 67.     CrossRef
Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4
Li-Jun Mo, Man Song, Qiao-Hua Huang, Hua Guan, Xiao-Dan Liu, Da-Fei Xie, Bo Huang, Rui-Xue Huang, Ping-Kun Zhou
British Journal of Cancer.2018; 119(4): 492.     CrossRef
An oasis in the desert of cancer chemotherapeutic resistance: The enlightenment from reciprocal crosstalk between signaling pathways of UPR and autophagy in cancers
Yuhang Zhang, Xianjun Qu, Lingfan Jiang
Biomedicine & Pharmacotherapy.2017; 92: 972.     CrossRef